placeholderImage

What is nasal vaccine? Bharat Biotech's intranasal COVID-19 vaccine's phase-1 trials to begin soon

DNA

News

12 Jan 2021

3m

News

India

U

Share

Watchlist

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI) for its COVID-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during February-March this year. Watch this video to know all about Intranasal COVID-19 Vaccine.